SRTS (Sensus Healthcare) Loans Receivable : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare Loans Receivable?

Sensus Healthcare's Loans Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.

Sensus Healthcare Loans Receivable Historical Data

The historical data trend for Sensus Healthcare's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare Loans Receivable Chart

Sensus Healthcare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Loans Receivable

Get a 7-Day Free Trial

Sensus Healthcare Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Loans Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Sensus Healthcare Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Sensus Healthcare Loans Receivable Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensus Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Loans Receivable

Comparable Companies

Traded in Other Exchanges

5TX:Germany

Address

851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487

Website

https://www.sensushealthcare.com

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Executives

John Heinrich	director	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Joseph C Sardano	director, officer: Chief Executive Officer	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano	officer: GENERAL COUNSEL	851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Samuel O'rear	director	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez	officer: Chief Operating Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall	director	851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro	officer: Chief Operating Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla	officer: Chief Financial Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen	officer: EXECUTIVE VICE PRESIDENT	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish	director	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman	officer: CHIEF TECHNOLOGY OFFICER	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin	officer: EXECUTIVE VICE PRESIDENT	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487